Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Diseases
en-GBde-DEes-ESfr-FR

Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Diseases

28/05/2025 Compuscript Ltd
https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0014
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular diseases (CVDs) are intricately linked, because of their widespread prevalence and shared pathophysiological processes. People who have experienced overlapping asthma exacerbation, persistent asthma, or asthma-chronic obstructive pulmonary disease (COPD) face elevated CVD morbidity and mortality risks. These risks are exacerbated in cases of type 2 asthma, a common phenotype of severe asthma leading to accelerated CVD progression. However, type 2 inflammation also exhibits protective effects against CVDs. This review explores the dual role of type 2 inflammation in CVDs, emphasizing its detrimental effects (e.g., exacerbating atherosclerosis) and protective mechanisms (e.g., release of atheroprotective cytokines such as IL-5 and IL-13). Furthermore, it examines the therapeutic potential of anti-asthma medications targeting type 2 inflammation to mitigate CVD progression.
# # # # # #
CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Mingze
Zhiyun Yang, Yingying Ge and Rui Zuo et al. Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Diseases. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2025.0014
Zhiyun Yang, Yingying Ge and Rui Zuo et al. Type 2 Inflammation: A Potential Clinical Link Between Asthma and Cardiovascular Diseases. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2025.0014
28/05/2025 Compuscript Ltd
Regions: Europe, Ireland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...

  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement